Parkinsonism & related disordersHumansDiabetes MellitusType 2Parkinson DiseaseRetrospective Studies
Incretin-based therapy and Parkinson's disease risk among patients with type 2 diabetes: Retrospective cohort study and meta-analysis.
Yael Barer, Tal Ast, Gabriel Chodick, Gilad Twig, Nir Giladi
Published: 202610.1016/j.parkreldis.2025.108171
Abstract
INTRODUCTION: Despite the widespread adoption of incretin-based therapy (IBT) for type 2 diabetes (T2D) and weight management, its potential neuroprotective effects remain inadequately characterized. Given emerging evidence of IBT's effects on neurod…
Preview only. Read the full abstract at the source